Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Charoen Pokphand Indonesia Tbk (CPIN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Charoen Pokphand Indonesia TbkTrading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Charoen Pokphand Indonesia Tbk dan Brigit Biofarmaka Teknologi Tbk.: Charoen Pokphand Indonesia Tbk diperdagangkan di Rp3.070 (kapitalisasi pasar 50,83 T, volume 24 jam 11,89 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Charoen Pokphand Indonesia Tbk jauh lebih besar — sekitar 303,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Charoen Pokphand Indonesia Tbk lebih aktif diperdagangkan (11,89 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.

CPINOBAT
Kapitalisasi Pasar
50,83 T167,37 M
Volume
11,89 jt71 rb
Lot
118,87 rb710
Perputaran
36,7 M17,51 jt
Harga Rata-rata
3.087,87246,63
Nilai Transaksi
36,7 M17,51 jt
Harga Ekuilibrium Indikatif
3.070246
Volume Ekuilibrium Indikatif
13,65 rb1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CPIN
Lihat detail
OBAT
Lihat detail

Tentang Charoen Pokphand Indonesia Tbk

PT Charoen Pokphand Indonesia Tbk (the Company) was established in Indonesia within the framework of Foreign Investment Law No. 1 year 1967 based on Notarial Deed No. 6 dated January 7, 1972 of Drs. Gde ngurah Rai, S.H. PT Charoen Pokphand Indonesia (CPI) established by CP Overseas Investment Co. Ltd., Hongkong. CPI is one of Indonesia leading agribusiness companies, with a clear focus on the formulation and production of poultry feed and the breeding of top quality poultry stock for Indonesian market. CPI is supported by expertise and experience of the established Charoen Pokphand Group of Thailand. The company has a fabrication plant, research and development facilities and breeding centers.

Selengkapnya di halaman CPIN

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT